An update on the contribution of the MHC to AS susceptibility
- PMID: 24838411
- PMCID: PMC4488903
- DOI: 10.1007/s10067-014-2662-7
An update on the contribution of the MHC to AS susceptibility
Abstract
The 40-year-old association of HLA-B27 with ankylosing spondylitis is one of the best examples of disease association with a hereditary marker. Genomewide association and family studies suggest that other important major histocompatibility complex (MHC) influences are operative in ankylosing spondylitis (AS) susceptibility. HLA-B27 positive hepatitis C individuals are immunologically more efficient in combating viral infections such as HIV-1, hepatitis C, and influenza and less efficient in combating against certain bacteria (and perhaps other organisms) capable of surviving intracellularly. A recent representative population survey of the frequency of HLA-B27 in the USA found a lower frequency of HLA-B27 in older US adults, perhaps reflecting this. Other HLA class I and class II alleles have been implicated in AS susceptibility, the most consistent being HLA-B*40/B60 (B*40:01) but also B14, B15, A*0201, DRB1*04:04, and certain DPA1 and DPB1 alleles. Non-HLA MHC alleles have also been implicated, although many such studies have been inconsistent, likely due to power issues related to the low number of HLA-B27-negative AS patients examined. The best evidence is for major histocompatibility complex class I chain-related gene A (MICA) whose recognition by intestinal epithelial T cells expressing different V-delta-1 gamma/delta TCR further implicates the gut in AS pathogenesis. The HLA class I and class II and other non-HLA allelic associations underscore the importance of T cells in AS pathogenesis.
Figures



Similar articles
-
HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population.Tissue Antigens. 2013 Dec;82(6):374-9. doi: 10.1111/tan.12238. Tissue Antigens. 2013. PMID: 24498993
-
Distribution of HLA-B27 in Romanian spondyloarthritides patients.Int J Immunogenet. 2010 Dec;37(6):513-6. doi: 10.1111/j.1744-313X.2010.00945.x. Int J Immunogenet. 2010. PMID: 20572892
-
HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility.Hum Immunol. 2000 Feb;61(2):131-9. doi: 10.1016/s0198-8859(99)00145-7. Hum Immunol. 2000. PMID: 10717805
-
Major histocompatibility genes and ankylosing spondylitis.Best Pract Res Clin Rheumatol. 2006 Jun;20(3):601-9. doi: 10.1016/j.berh.2006.03.004. Best Pract Res Clin Rheumatol. 2006. PMID: 16777585 Review.
-
Killer immunoglobulin receptor genes in spondyloarthritis.Curr Opin Rheumatol. 2016 Jul;28(4):368-75. doi: 10.1097/BOR.0000000000000302. Curr Opin Rheumatol. 2016. PMID: 27166924 Review.
Cited by
-
The role of the unfolded protein response in axial spondyloarthritis.Clin Rheumatol. 2016 Jun;35(6):1425-31. doi: 10.1007/s10067-015-3117-5. Epub 2015 Nov 14. Clin Rheumatol. 2016. PMID: 26567900 Review.
-
Genetics and Functional Genomics of Spondyloarthritis.Front Immunol. 2018 Dec 18;9:2933. doi: 10.3389/fimmu.2018.02933. eCollection 2018. Front Immunol. 2018. PMID: 30619293 Free PMC article. Review.
-
Update on ankylosing spondylitis: current concepts in pathogenesis.Curr Allergy Asthma Rep. 2015 Jan;15(1):489. doi: 10.1007/s11882-014-0489-6. Curr Allergy Asthma Rep. 2015. PMID: 25447326 Review.
-
Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy.Genes (Basel). 2017 Apr 24;8(4):127. doi: 10.3390/genes8040127. Genes (Basel). 2017. PMID: 28441778 Free PMC article.
-
Ankylosing spondylitis: etiology, pathogenesis, and treatments.Bone Res. 2019 Aug 5;7:22. doi: 10.1038/s41413-019-0057-8. eCollection 2019. Bone Res. 2019. PMID: 31666997 Free PMC article.
References
-
- Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704–706. - PubMed
-
- Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A. 27. Lancet. 1973;301(7809):904–907. - PubMed
-
- Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823–1828. - PubMed
-
- Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004;50:2246–2254. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials